These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38969631)

  • 1. Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response.
    Coulton A; Murai J; Qian D; Thakkar K; Lewis CE; Litchfield K
    Nat Commun; 2024 Jul; 15(1):5665. PubMed ID: 38969631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.
    Toledo B; Zhu Chen L; Paniagua-Sancho M; Marchal JA; Perán M; Giovannetti E
    J Hematol Oncol; 2024 Jun; 17(1):44. PubMed ID: 38863020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma.
    Shao G; Cui X; Wang Y; Luo S; Li C; Jiang Y; Cai D; Li N; Li X
    CNS Neurosci Ther; 2024 Jul; 30(7):e14791. PubMed ID: 38997808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials.
    Zhang W; Wang M; Ji C; Liu X; Gu B; Dong T
    Biomed Pharmacother; 2024 Aug; 177():116930. PubMed ID: 38878638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
    Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H; Chen Y; Niu H; Li X; Gai X; Cui G
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
    Mojsilovic SS; Mojsilovic S; Villar VH; Santibanez JF
    Anal Cell Pathol (Amst); 2021; 2021():5523055. PubMed ID: 34476174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Li Z; Chen Z; Shi W; Xu Y; Huang Z; Lin Z; Dou R; Lin S; Jiang X; Li M; Jiang S
    Aging (Albany NY); 2024 Apr; 16(8):6809-6838. PubMed ID: 38663915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy.
    Wang YC; Wang X; Yu J; Ma F; Li Z; Zhou Y; Zeng S; Ma X; Li YR; Neal A; Huang J; To A; Clarke N; Memarzadeh S; Pellegrini M; Yang L
    Nat Commun; 2021 Jun; 12(1):3530. PubMed ID: 34112755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs.
    Jung M; Bonavida B
    Crit Rev Oncog; 2024; 29(4):1-17. PubMed ID: 38989734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
    Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
    J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
    Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
    Front Immunol; 2020; 11():1731. PubMed ID: 32849616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
    Li X; Zhang Q; Chen G; Luo D
    Front Immunol; 2021; 12():694801. PubMed ID: 34295336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages: The key player in hepatoblastoma microenvironment and the promising therapeutic target.
    Adawy A; Komohara Y; Hibi T
    Microbiol Immunol; 2024 Aug; 68(8):249-253. PubMed ID: 38923004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors.
    Park SM; Chen CJ; Verdon DJ; Ooi MPY; Brooks AES; Martin RCW; Mathy JA; Emanuel PO; Dunbar PR
    Front Immunol; 2024; 15():1412076. PubMed ID: 38903497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
    Scott EM; Jacobus EJ; Lyons B; Frost S; Freedman JD; Dyer A; Khalique H; Taverner WK; Carr A; Champion BR; Fisher KD; Seymour LW; Duffy MR
    J Immunother Cancer; 2019 Nov; 7(1):320. PubMed ID: 31753017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using macrophage activation to augment immunotherapy of established tumours.
    Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
    Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.